China NMPA Product Recall - Intra-aortic balloon counterpulsation pump

The National Medical Products Administration (NMPA) announced a Level 1 voluntary recall initiated by Datascope Corp. for its Intra-Aortic Balloon Counterpulsation Pumps, with the recall details published on August 9, 2019. The issue, reported by Maikewei (Shanghai) Medical Equipment Co., Ltd., stems from a critical flaw where battery maintenance was not performed according to the product's instructions. This oversight could lead to the device's battery operating for a duration less than its minimum expected life when running on battery power. Datascope Corp. is proactively recalling affected units, classified as Level 1 by the NMPA, indicating a serious health hazard. This recall highlights the NMPA's rigorous regulatory framework, which mandates prompt action from manufacturers to address and rectify product deficiencies to ensure patient safety and product reliability.